These can include any of the following: Age: It is more common for people over age 65 to have kidney or liver issues, and this can affect how the medication is metabolized or processed in the body and how much of it becomes available to use
(To counter this, some doctors prescribe phentermine on and off so patients can take a break in between treatment cycles)
report symptoms such as right upper abdominal pain, nausea, or vomiting Diabetic retinopathy complications : Particularly with semaglutide, rapid improvement in blood glucose can temporarily worsen existing retinopathy
Areas with thinner subcutaneous layers may show variable absorption rates
Physicians at Cedars-Sinai and Hackensack Meridian Health have observed that patients pursue lower steady doses primarily for three reasons: gastrointestinal tolerability, weight maintenance after significant loss on a standard-dose protocol, or metabolic and non-weight goals
To examine longer-term associations of semaglutide with AUD, the outcome incident and recurrent diagnosis of AUD in patients with T2DM was further followed for 2-year, 3-year starting after the index event
